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Rapid identification of pathogens, 
antibiotic resistance genes and 
plasmids in blood cultures by 
nanopore sequencing
Arne M. taxt1,2, Ekaterina Avershina2, Stephan A. frye1, Umaer naseer3 & Rafi Ahmad2,4 ✉
Bloodstream infections (BSI) and sepsis are major causes of morbidity and mortality worldwide. 
Blood culture-based diagnostics usually requires 1–2 days for identification of bacterial agent and 
an additional 2–3 days for phenotypic determination of antibiotic susceptibility pattern. With the 
escalating burden of antimicrobial resistance (AMR) rapid diagnostics becomes increasingly important 
to secure adequate antibiotic therapy. Real-time whole genome sequencing represents a genotypic 
diagnostic approach with the ability to rapidly identify pathogens and AMR-encoding genes. Here 
we have used nanopore sequencing of bacterial DNA extracted from positive blood cultures for 
identification of pathogens, detection of plasmids and AMR-encoding genes. To our knowledge, this is 
the first study to gather the above-mentioned information from nanopore sequencing and conduct a 
comprehensive analysis for diagnostic purposes in real-time. Identification of pathogens was possible 
after 10 minutes of sequencing and all predefined AMR-encoding genes and plasmids from monoculture 
experiments were detected within one hour using raw nanopore sequencing data. Furthermore, we 
demonstrate the correct identification of plasmids and blaCTX-M subtypes using de novo assembled 
nanopore contigs. Results from this study hold great promise for future applications in clinical 
microbiology and for health care surveillance purposes.
Bloodstream infections (BSIs) and sepsis are major causes of morbidity and mortality worldwide. Epidemiological 
data are scarce, but a recent estimate indicated that 31.5 million cases of sepsis and 5.3 million sepsis attributable 
deaths occur annually1. This estimate is only based on data collected from high-income countries, and it therefore 
likely underestimates the true burden of disease worldwide, especially in low-and-middle-income countries2. 
Most studies on sepsis and BSIs report an increasing incidence over the last two decades3, particularly among 
the immunocompromised, multimorbid, and elderly patients, or due to failure of empiric antibiotic regimens as 
result of antimicrobial resistance (AMR)4.
With multi drug resistant pathogens spreading at an alarming rate, widely adopted empirical antibiotic treat-
ment regimens for sepsis based on penicillin (or aminopenicillin) in combination with gentamicin5 are being 
challenged. In particular, the escalating burden of infections due to extended-spectrum β-lactamase (ESBL) 
producing Gram negative bacteria represents a major health concern. These bacteria, mainly Escherichia coli 
and Klebsiella pneumoniae, are not only resistant to all penicillins and third generation cephalosporins, but also 
frequently express co-resistance to gentamicin. Consequently, treatment failure may occur, and clinicians increas-
ingly prescribe last-resort antibiotics such as carbapenems as initial antibiotic treatment of sepsis. This in turn 
contributes to development and spread of AMR and to a further increase in the burden of infections caused by 
resistant bacteria.
Current state-of-the art in diagnostics of BSIs is blood culture, which often takes 1–3 days to come out positive 
and provide information on etiological agent. Time to positivity is influenced by a number of clinical and micro-
biological factors such as source of bacteraemia, level of bacteraemia, presence or absence of pre-administered 
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antibiotics and the bacterial species6. Use of matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) mass spectrometry is becoming widespread in clinical microbiology laboratories to identify 
bacteria by analysis of pelleted blood-cultures when they are flagged as positive by the blood culture incuba-
tion system7. Phenotypic antimicrobial susceptibility testing (AST) however, requires subculture on solid media 
overnight for colonies to form, and an additional 18+/−2 hours of subculture incubation with antibiotic discs 
to obtain a result which can be interpreted according to official breakpoint guidelines and converted to sensitive 
(S), intermediate (I) or resistant (R)8. Until then time-point choice of antibiotic treatment is based on clinical 
assessment, empirical guidelines and local epidemiology on AMR. However, several studies have observed that 
inappropriate antibiotic treatment is often initiated to patients with BSIs and this is associated with increased 
mortality9,10.
Diagnosis of BSI and prescription of appropriate antimicrobial therapy is crucial for the reduction of mor-
bidity and mortality caused by BSI and WHO and Centers for Disease Control aim for a two hour turnaround 
time11. For these reasons there is a growing interest and an urgent need for the development of molecular tech-
niques for rapid identification of pathogens and AMR from blood and blood cultures. The topic has been exten-
sively reviewed elsewhere12–14, and the currently available methods can be categorized in three groups; in situ 
hybridization-based methods, DNA-microarray-based methods, nucleic acid amplification-based methods (such 
as PCR and loop-mediated isothermal amplification (LAMP)), and combinations of these. Common to all these 
techniques is that detection is limited to a predefined set of genetic targets, either specific for a particular path-
ogen or an AMR-encoding gene. Whole genome sequencing (WGS) on the other hand, provides comprehen-
sive genomic information and can potentially detect all AMR-encoding genes present in the bacterial genome. 
Additionally, WGS-data provide vast opportunities for bacterial sequence typing, phylogenetics and virulence 
analysis. The introduction of the real-time sequencing platform from Oxford nanopore technology (ONT) has 
triggered studies to explore its application in blood culture diagnostics, either based on 16 s amplicon sequenc-
ing15, or by a whole-genome-sequencing approach16. This represents an unbiased approach to diagnostics with 
the potential to identify any pathogen and AMR-encoding gene.
Here we present results from rapid blood culture diagnostics based on extraction of bacterial DNA from 
positive blood cultures followed by nanopore sequencing and real-time data analysis for identification of 
pathogens, detection of plasmids and AMR-encoding genes. The results have also been verified through WGS 
using short-read Illumina sequencing and hybrid assembly using nanopore and Illumina sequences. This 
proof-of-concept study represents a molecular-genetic approach to diagnosis of BSIs which can provide clinicians 
with detailed information on etiologic agent and AMR within few hours of a blood culture becoming positive.
Results
Blood culture samples and nanopore sequencing. Seven blood cultures spiked with blaCTX-M posi-
tive E. coli and K. pneumoniae, mecA positive Staphylococcus aureus, or a combination of these were analysed. 
In addition, one blood culture was spiked with E. coli reference strain CCUG17620 (non-ESBL) as control. All 
cultures were incubated in a standard BD BACTEC FX blood culturing instrument with continuous monitoring 
until flagged positive. Positive monocultures had bacterial concentrations ranging from 2.6 × 107 to 1.6 × 109 
CFU/ml. When E. coli and S. aureus were co-cultured, we observed a 4-log difference in bacterial concentration 
in favour of E. coli, while for the E. coli and K. pneumoniae co-culture the difference was less than one-log fold in 
favour of K. pneumoniae (Table 1).
For extraction of bacterial DNA, the commercially available kits MolYsis Plus and BiOstic Bacteremia DNA 
were both used initially. Subsequent experiments were conducted using the BiOstic Bacteremia DNA kit due to its 
shorter protocol and higher DNA yield (Supplementary Fig. 1). Purified DNA was subject to nanopore sequenc-
ing on the MinION sequencing platform from ONT. The average amount of data generated was 334,113 ± 379,926 
(mean ± standard deviation) sequencing reads per blood culture with an average read length of 3,529 ± 4,140 bp 
(Supplementary Fig. 2). Only 15.4% ± 14.4% of the reads were shorter than 300 bp, which is the maximum 
single-end read length generated by the latest version of the Illumina MiSeq system.
Nr Bacteria AMR gene CFU/ml DNA [ng/µl]
1 E. coli (CCUG17620) − 1,3 × 109 60
2 E. coli (A2-39) CTX-M-2 1,6 × 109 57
3 E. coli (NCTC13441) CTX-M-15 1,7 × 109 49
4 K. pneumoniae(A2-23) CTX-M-1 9,3 × 108 54
5 K. pneumoniae(A2-37) CTX-M-14 1,0 × 109 56
6 S. aureus(CCUG35600) mecA 2,6 × 107 31
7
E. coli (A2-239) CTX-M-2 5,5 × 107
45+ +
K. pneumoniae (A2-37) CTX-M-14 4,8 × 108
8
E. coli (NCTC13441) CTX-M-15 1,2 × 109
54+ +
S. aureus (CCUG35600) mecA 3,6 × 105
Table 1. Overview of blood culture experiments.
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Bacterial species identification using raw nanopore sequencing reads. Using default settings, the 
Metrichor analysis platform from ONT performed real-time base calling generating 4,000 sequences per output 
file. For taxonomy assignment, both Centrifuge17 classification (used by the ONT analysis tool What´s In My 
Pot (WIMP)18) and BLAST search against the NCBI Prokaryotic RefSeq (RefProk) database took less than one 
minute per sequencing file using four cores, which is the standard configuration on current laptops. We hereby 
present detailed results for two monoculture experiments, E. coli A2-39 and K. pneumoniae A2-37, and for one 
blood culture spiked with both of these isolates.
Based only on the first sequence file 80–100% of bacterial reads were classified correctly at the species level by 
BLAST search against the RefProk database (Fig. 1D–F) and most of the ‘incorrect’ assignments, i.e. reads classi-
fied as non-target bacteria, comprised less than 1% per species (Fig. 2A–C). Also, relative amounts of the detected 
species remained constant throughout the sequencing run (Fig. 2A–C).
Intriguingly, 4.3% of sequencing reads from E. coli A2-39 monoculture and 1.7% of reads from the E. coli 
A2-39 + K. pneumoniae A2-37 mixed culture were classified as belonging to Salmonella enterica by Centrifuge, 
but not by BLAST (Fig. 1A,C,D and F). Following a detailed analysis, the majority of these misclassified 
reads were identified as E. coli specific sequences using BLAST against the RefProk and RefSeq databases 
(Supplementary Fig. 3). The average nucleotide identity (ANI) values of these reads were 79.6% for Salmonella 
enterica (AE014613.1) and 83.6% for E. coli (NC_000913.3). Around 9% of E. coli A2-39 culture reads were 
classified as Shigella by BLAST search against RefProk database, with ANI values of 87.9% for Shigella flexneri 
(AE014073.1) and 88.8% for E. coli (NC_000913.3).
In both analyses of the K. pneumoniae A2-37 isolate, in monoculture and in the E. coli A2-39 + K. pneumoniae 
A2-37 mixed culture, K. pneumoniae A2-37 reads were evenly classified as K. pneumoniae, K. quasipneumoniae 
or K. variicola by Centrifuge (Fig. 1B,C). However, BLAST search against RefProk classified all of these reads as 
K. pneumoniae (Fig. 1E,F). ANI values for these reads were on average 85.2% for reads assigned to K. pneumoniae 
(NC_016845.1), 84.2% for reads assigned to K. variicola (NZ_CP010523.2) and 87.0% for reads assigned to K. 
quasipneumoniae (NZ_CP014696.2).
The other four monoculture experiments of E. coli, K. pneumoniae and S. aureus also showed very promising 
results, with 94-100% of reads assigned correctly to target species using the first 4000 reads (Supplementary 
Fig. 4). In the mixed culture experiment with E. coli and S. aureus however, 94.7% of sequences were assigned to 
E. coli and only 0.05% of reads were assigned to S. aureus based on the first sequence file. Throughout the entire 
sequencing run the relative number of reads classified as S. aureus remained below 1% and were thereby indistin-
guishable from other low-level misassignments. A probable explanation could be the 4-log difference in bacterial 
concentration in favour of E. coli in the experiment (Table 1).
Figure 1. Relative distribution of reads in sequence data generated by nanopore sequencing of DNA purified 
from the three selected blood cultures. The blood cultures were spiked with E. coli A2-39 (A and D), K. 
pneumoniae A2-37 (B and E) and E. coli A2-39 + K. pneumoniae A2-37 (C and F). Upper panel (A–C) show 
results obtained using Centrifuge and lower panel (D–F) show results based on BLAST search against the 
RefProk database that contains prokaryotic sequence data only. The “Others” group represents taxa with relative 
read counts below 1%. All results are based only on the first output file for each experiment from the MinION 
sequencing platform, containing 4000 reads (available after approximately 10 minutes of sequencing).
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Detection of AMR-encoding genes and plasmids using raw nanopore sequencing reads. BLAST 
search against the CARD and ResFinder databases showed similar AMR gene assignments and therefore these 
results are presented together. In case of the reference strain (E.coli CCUG17620) spiked blood culture none of 
the reads were identified as blaCTX-M positive. For all monocultures of blaCTX-M or mecA-positive bacteria, target 
AMR genes were detected within the first hour of sequencing (Fig. 3). However, the unassembled sequencing data 
did not allow correct identification of blaCTX-M gene variant (Supplementary Fig. 5). Sequencing reads containing 
blaCTX-M genes were recognized as plasmid-borne when BLAST search of these reads against the plasmid database 
from Brooks et al.19 yielded positive hits (Fig. 3). The mecA positive reads from the S. aureus spiked blood culture 
were not detected in the plasmid database and therefore were labelled as chromosome borne. The first blaCTX-M 
containing read from the E. coli A2-39 + K. pneumoniae A2-37 spiked blood culture was detected 10 minutes after 
the start of sequencing. Ten minutes were also enough to capture the first blaCTX-M containing read from the E. 
coli NCTC 13441 + S. aureus CCUG35600 spiked blood culture, but the first indication of the mecA gene came 
only after 16 hours.
De novo assembled nanopore contigs enable identification of plasmids and blaCTX-M 
gene-variants. Using de novo assembled contigs from E. coli A2-39 and K. pneumoniae A2-37 monoculture 
experiments we searched for plasmids with the NCBI PlasmidFinder tool. E.coli A2-39 harboured IncHI2, IncI1 
and p0111 plasmids, whereas K. pneumoniae A2-37 harboured IncFII and IncFI plasmids (Table 2). Assembled 
contigs from sequencing of the blood culture spiked with both isolates also suggested presence of these plas-
mids. By performing additional BLAST searches with the plasmid-labelled contigs against the AMR databases the 
blaCTX-M gene-variants could be identified (Table 2).
To assess whether the first raw sequencing reads that were recognized as containing blaCTX-M were 
plasmid-borne, they were mapped to the de novo assembled contigs. The E. coli A2-39 blaCTX-M-containing 
read detected after 59 minutes of sequencing mapped to the IncHI2-tagged contig with 92.1% identity 
(length = 3,961 bp; query coverage = 100%; e-value = 0), whereas the K. pneumoniae A2-37 blaCTX-M con-
taining read detected after 10 minutes of sequencing mapped to the IncFII-tagged contig with 94% identity 
(length = 2,055 bp; query coverage = 100%; e-value = 0). The first blaCTX-M containing read from the E. coli 
A2-39 + K. pneumoniae A2-37 spiked blood culture that was detected after ten minutes of sequencing, mapped 
only to the IncFII-tagged K. pneumoniae contig with 91.2% identity (length = 3 840 bp; query coverage = 100%; 
e-value = 0). The first read that mapped to the IncHI2-tagged E. coli contig, was detected in the second output file 
generated after 36 minutes of sequencing (length = 4 178 bp; query coverage = 99.9%; identity = 91.2%; e-value 
= 0).
Figure 2. Centrifuge-based relative taxonomic assignments of sequence data from DNA purified from the 
three selected blood cultures. Samples were spiked with - (A) E. coli A2-39, (B) K. pneumoniae A2-37 and (C) 
E. coli A2-39 + K. pneumoniae A2-37. The “Others” group shows the average relative amount of all incorrectly 
assigned (non-target) taxa. Blood cultures spiked with E. coli (A2-39) and with a combination of E. coli (A2-39) 
and K. pneumoniae (A2-37) were sequenced for 68 and 64 hours respectively.
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Identification of bacterial species, AMR-encoding genes and plasmids using raw Illumina 
sequencing reads. To verify taxonomic classification, AMR-gene detection and plasmid identification, the 
E. coli A2-39 and K. pneumoniae A2-37 isolates were sequenced on an Illumina MiSeq platform. Taxonomic 
assignment of the unassembled Illumina reads by Centrifuge was similar to the results obtained with nanopore 
data; where 4.7% of the E. coli A2-37 reads were assigned as S. enterica, and K. pneumoniae reads were assigned as 
a combination of K. pneumoniae, K. quasipneumoniae and K. variicola group (Supplementary Fig. 6). For detec-
tion of AMR-encoding genes, CARD and ResFinder databases were searched using SPAdes assembled contigs 
(see Supplementary Table 1 for details). This suggested that E. coli A2-39 harboured an IncHI2 plasmid encoding 
the blaCTX-M-2 gene (hit length = 876 bp; identity = 100%; e-value = 0) and that K. pneumoniae A2-37 contained 
an IncFII plasmid with the blaCTX-M-14 gene (hit length = 876 bp; identity = 100%; e-value = 0).
Hybrid de novo assembled data corroborate nanopore results. Hybrid de novo assembly using 
Illumina reads and nanopore reads from blood cultures spiked with E. coli A2-39 or K. pneumoniae A2-37 was 
performed using Unicycler (Fig. 4 and Supplementary Table 1). Generally, hybrid assembled data corroborated 
results obtained using nanopore assembled data only, albeit with higher precision. The blaCTX-M-2 gene variant 
was detected in E. coli A2-39 (identity = 100%; hit coverage = 100%; e-value = 0) and K. pneumoniae A2-37 
was found to carry blaCTX-M-14 (identity = 100%; hit coverage = 100%; e-value = 0). Three contigs were tagged 
as plasmid-borne by PlasmidFinder (Supplementary Table 2). Additional search with these contigs against the 
PLSDB database revealed that one circular contig of the hybrid E. coli A2-39 assembly (length = 231,378 bp) had 
Figure 3. Overview of the earliest generated reads from each sequencing experiment where blaCTX-M (yellow) 
or mecA genes (green) and plasmid-derived sequences (red) were identified based on BLAST search. Blue 
lines represent length of the nanopore reads, length of hits is illustrated by arrow-length and similarity to the 
database entry is given on the arrow. The time of read generation is noted on top of each read.
Bacterial culture
PlasmidFinder Resistance genes database
Plasmid type
Query/HSP 
length, bp Identity, %
CTX-M 
variant Hit length, bp Identity, % E-value
E. coli (A2-39)
IncHI2 327/327 100




CTX-M-14 877 99.5 0IncFIA 388/388 97.2
IncFIB 512/560 98.2
E. coli (A2-39) +K. 
pneumoniae (A2-37)
IncHI2 630/630 99.2
CTX-M-2 877 99.3 0
p0111 885/885 98.8
IncFIA 388/388 96.9
CTX-M-14 876 100 0IncFIB 560/560 98.7
IncFII 261/261 100
Table 2. BLAST search results of contigs harbouring plasmids against the AMR databases. HSP – high scoring 
segment pair.
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99.8% identity to the IncHI2A E. coli RCS77_p plasmid (LT985297.1). The other circular contig (length = 95,977) 
had 98.0% identity to the p0111_1 Enterobacteriaceae plasmid (NZ_CP033848.1) and a non-circular contig had 
99.6% identity to the IncI1 E. coli pS51_1 plasmid (NZ_CP015996.1).
One circular contig of the K. pneumoniae A2-37 hybrid assembly (length = 84,474 bp; depth = 2.41×) labelled 
as IncFII by PlasmidFinder had 99.8% identity to the IncFII E. coli pFAM22321 plasmid (KU288634.1). Two 
non-circular contigs of the K. pneumoniae A2-37 hybrid assembly (length = 128,678 bp and length = 121,056 bp) 
were recognized by PlasmidFinder as plasmids IncFIA(HI1) and IncFIB(K) (Supplementary Table 2). Additional 
search of these contigs through the PLSDB database showed that they had 93.8% identity to K. pneumoniae pKp_
Goe_414-3 plasmid (NZ_CP018340.1) and 96.6% identity to K. pneumoniae strain AR_0049 unitig_2 plasmid 
(NZ_CP018818.1) respectively.
The first blaCTX-M containing read from the E. coli A2-39 monoculture detected after one hour of sequencing 
mapped to the IncHI2 plasmid contig with 92.4% identity (length = 4,100 bp; query coverage = 100%; e-value = 
0). The first blaCTX-M containing read from the K. pneumoniae A2-37 monoculture detected after 10 minutes of 
sequencing mapped to the IncFII contig with 94.8% identity (length = 2,109 bp; query coverage = 100%; e-value 
= 0). Similar to the assembled nanopore data, the first blaCTX-M tagged read from the E. coli A2-39 + K. pneu-
moniae A2-37 spiked blood culture mapped to the K. pneumoniae A2-37 hybrid assembly with 91.2% identity 
(length = 4,005 bp; query coverage = 100%; e-value = 0), but not to the E. coli A2-39 hybrid assembly. The first 
blaCTX-M tagged read that mapped to the E. coli A2-39 hybrid assembly (length = 4,349 bp; query coverage = 
99.9%; identity = 91.0%; e-value = 0), was found in the second output file generated 36 minutes after the sequenc-
ing start.
Plasmid sequence analysis suggests horizontal gene transfer between Salmonella species 
and E. coli. Interestingly, 52.2% of the reads that were identified as S. enterica by Centrifuge in the E. coli 
A2-39 experiment mapped to plasmid-tagged contigs. Two thirds of these reads (1117 out of 1917) mapped 
to the blaCTX-M-2 harbouring IncHI2A plasmid contig (Fig. 4A–C). Moreover, this contig showed 99.7% iden-
tity to IncHI2 plasmids isolated from S. enterica subsp. enterica serovar Enteritidis strains (KM396300.1; 
KM396299.1 and KM396298.1), suggesting horizontal gene transfer between Salmonella species and E. coli. Of 
the Shigella-tagged reads from the same experiment the majority (81.6%) were evenly distributed across E. coli 
A2-39 chromosomal contigs and 18.4% mapped to plasmid contigs, mainly to the IncHI2A plasmid contig (929 
out of 950 reads) (Supplementary Fig. 7).
Eight hours of nanopore sequencing is sufficient for 95% genome coverage. For the majority of 
monocultures, there was a steep increase to 95% genome coverage within the first two-four hours of sequencing 
(Fig. 5). Then accumulation of new information slowed down and genome coverage reached 99.0–99.8% after 
six hours of sequencing. In case of the K. pneumoniae A2-37 monoculture, which had more than 50% of human 
reads, it took eight hours to reach 95% genome coverage, 20 hours to reach 98.5% and 44.5 hours to reach 99.0% 
genome coverage (Fig. 5A). For the E. coli (A2-39) and K. pneumoniae (A2-37) spiked blood culture, it took only 
2 hours to cover 95% of the K. pneumoniae (A2-37) genome as opposed to 5 hours to reach 95% coverage of E. coli 
(A2-39) genome (Fig. 5B). For the E. coli (NCTC13441) and S. aureus (CCUG35600) spiked blood culture, where 
Figure 4. Assembly graphs for E. coli A2-39. (A) Hybrid assembly of nanopore and Illumina data; reads 
tagged as S. enterica by Centrifuge and blaCTX-M are highlighted (S. enterica in multicolour, blaCTX-M in blue). 
The blaCTX-M gene was located on a plasmid-derived read which mapped to the IncHI2 plasmid. (B) Unicycler 
assembled nanopore generated data. (C) SPAdes assembled Illumina generated data.
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the difference in bacterial concentration comprised 4-log, the E. coli (NCTC13441) genome was fully covered 
within the first hour of sequencing, whereas at 16 hours, when the mecA gene was detected, sequencing reads 
comprised information only on 25% of the S. aureus (CCUG35600) genome (Fig. 5C).
Discussion
In this proof-of-concept study we present a sequencing-based approach to blood stream infection diagnostics that 
can identify pathogens and detect AMR-encoding genes within four hours from the time point when a blood cul-
ture is flagged as positive. By rapidly providing clinicians with bacterial pathogen identification and alerting them 
to the presence of clinically relevant AMR-encoding genes, this can contribute to early optimization of antibiotic 
therapy. Firstly, such an approach can save lives by triggering a change in antibiotic treatment in cases where inad-
equate therapy is given. Secondly, when established and validated further, this approach may contribute to early 
de-escalation of broad-spectrum therapy and antibiotic stewardship when no clinically relevant AMR-encoding 
genes are detected. Genotypic sequencing-based blood-culture diagnostics therefore represents a promising sup-
plement to conventional phenotypic antimicrobial susceptibility testing.
In this study, we have shown that by use of the first 4000 raw sequencing reads, which become available after 
approximately 10 minutes of real-time sequencing, we can identify pathogens with a high degree of certainty. 
However, results obtained with Centrifuge (which is also utilized by the ONT analysis software WIMP) and 
search by BLAST differed substantially. Centrifuge is a very rapid tool for the classification of DNA sequences 
from microbial samples, which uses an indexing scheme optimized for the metagenomic classification. Here we 
have used the bacteria, archaea, virus and human indexing scheme for Centrifuge, which is derived from the 
NCBI Reference sequences (RefSeq) database. For the BLAST searches we used the NCBI Reference Prokaryotic 
Figure 5. Genome coverage of target species over time. (A) Blood cultures spiked with monocultures. 
Reference strain E. coli (NCTC13441) experiment was stopped after 2 hours; at that point it reached 84% of the 
genome coverage. (B) Blood culture spiked with a combination of E. coli (A2-39) and K. pneumoniae (A2-23) 
(C) blood culture spiked with a combination of E. coli (NCTC13441) and S. aureus (CCUG35600). S. aureus 
reached 35% coverage by the end of the sequencing run of 33 hours. Dashed horizontal line denotes 95% 
genome coverage.
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(RefProk) database, which only contains prokaryotic genomic data. For this reason, human sequences are only 
recognized with the former approach. Using Centrifuge 4.3% of E. coli A2-39 reads were classified as S. enterica, 
and around half of these reads mapped to different plasmids (one third mapped to the IncHI2 plasmid), while the 
rest mapped to the E. coli chromosome. Since these sequences were correctly assigned to E. coli by the RefProk 
database search, possibly some of this E. coli genomic information is lacking in the indexed Centrifuge database, 
or misclassification is caused by the Centrifuge algorithm. The misclassification of the plasmid-sequences by 
Centrifuge highlights how mobile genetic elements may pose a challenge to sequence-based identification of bac-
teria. Bacterial identification should primarily be based on chromosomal gene content. Centrifuge also assigned 
reads from the K. pneumoniae A2-37 experiment to three different subspecies of Klebsiella; K. pneumoniae, K. 
quasipneumoniae and K. variicola, whereas BLAST search against RefProk classified 100% of reads as originating 
from K. pneumoniae. Also, these reads were classified correctly as K. pneumoniae when using BLAST search 
against the RefSeq database, indicating that the misclassification was potentially due to the Centrifuge search or 
indexing algorithm and not the RefSeq database.
For our monoculture experiments, classification by BLAST against RefProk assigned 100% of reads correctly 
for K. pneumoniae and S. aureus, whereas for the four E. coli experiments a slight proportion (from 3.1% to 9.3%) 
where assigned to Shigella spp. The distinction between Shigella spp. and E. coli is a well-known challenge to 
clinical microbiology since they share many biochemical, phenotypic and genetic properties. Shigella is widely 
believed to have evolved from E. coli and the genus Shigella comprises several clusters interspersed in the E. coli 
phylogeny20. Also, mapping of the Shigella tagged reads to E. coli A2-39 showed the reads to be distributed across 
the chromosome (Supplementary Fig. 6). Moreover, only 9% of these Shigella-tagged reads had more than 80% 
similarity to the essential E. coli genes downloaded from the database of essential genes21. The Shigella virulence 
plasmid, which is the key molecular signature of Shigella spp., was not found. For the differentiation between E. 
coli and Shigella, plasmid-encoded genetic information may be essential.
For this study we selected blaCTX-M carrying strains of E. coli and Klebsiella, and a mecA positive strain of S. 
aureus for generation of mock blood-culture samples. These pathogens were selected because they are among 
the most frequently isolated bacteria from BSIs. Furthermore, the ESBL phenotype of Enterobacteriaceae and 
the MRSA phenotype of S. aureus are spreading globally at an alarming rate and are on the World Health 
Organization’s list of priority pathogens for which new antibiotics is urgently needed. In our monoculture exper-
iments these target AMR-encoding genes were detected within the first hour (10–59 minutes) of sequencing. By 
conventional microbiological methods the presence of ESBL or MRSA would not have been detected until 1–2 
days later, a delay which in the setting of BSIs can be fatal. We have also shown that, for most of the samples one to 
five hours of sequencing was enough to cover 95% of the target species genome. Also, even when more than half 
of the generated reads were of human origin, eight hours of sequencing was enough.
For mixed cultures the sequencing-based approach performed well when bacteria were present in approximately 
equal amounts, but for the E. coli and S. aureus experiment, where there was a 4-log difference in bacterial concentra-
tion in favour of E. coli, identification of both bacteria and AMR-encoding genes was challenging. After 10 minutes of 
sequencing 95% of reads were classified as E. coli and only 0.05% as S. aureus. The blaCTX-M gene of E. coli was detected 
in the first sequencing file, but the mecA gene of S. aureus was only detected after 16 hours of sequencing when ca. 
25% of its genome was sequenced. Diagnosing mixed infections, however, is also problematic using conventional 
microbiological methods. Analysis by MALDI-TOF of pelleted blood-cultures is often unsuccessful in these cases, 
and overnight sub-cultures on solid culture-media are required for identification from bacterial colonies. Phenotypic 
AST may take 3 days, since a monoculture is required before AST can be performed.
Raw nanopore reads allow for rapid detection of the blaCTX-M and mecA genes, but not further subtyping of 
blaCTX-M gene-variants. However, by use of de novo assembled nanopore contigs we can correctly identify both 
plasmids and blaCTX-M subtypes, thereby increasing the precision level substantially. This approach, possibly in 
combination with rapid bacterial sequence typing22 harbours great potential for future health care surveillance 
purposes. For Illumina the time taken from DNA extraction to normalized library was ~5.5 hours when using the 
Nextera XT DNA library preparation kit as opposed to ca. 3 hours needed for Nanopore library preparation. The 
additional time to be used for the sequencing by synthesis is very much dependent on the read length and in our 
case with a maximum read length of 2 × 300 bp, a runtime lasted about 56 hours. Although we kept MinION runs 
for up to 68 hours, the crucial difference between these two platforms is that in case of Nanopore sequencing, the 
data become available in real-time, whereas in case of Illumina, one has to wait until the end of the sequencing 
run. We are aware of very few studies which have applied nanopore whole genome sequencing for blood-culture 
diagnostics15,16,23. Recently, Sakai et al.16 applied multiple samples on each flow cell by use of barcoding and col-
lected sequencing data for 30 minutes, thereby obtaining 100–3000 reads per sample only. Analysis was done 
using the ONT analysis software WIMP, which utilizes Centrifuge. The authors report the top three bacteria with 
the highest read count, and the species with the most assigned reads was used for diagnosis. This approach per-
formed well for Gram negative bacteria but performed poorly for Gram positive bacteria. The study supports the 
feasibility of rapid nanopore-based identification of pathogens from blood cultures with a minimum of laboratory 
requirements. Based on our data however, we believe this approach does not generate enough data per isolate for 
reliable detection of all relevant AMR-encoding genes present in the sample.
It should be possible to develop a bioinformatic analysis pipeline that assembles nanopore data as they become 
available, performs plasmids search and AMR search against a database of clinically important AMR-encoding 
genes, and alerts the clinical microbiologist to important findings with very high precision. To implement such 
an approach in a routine clinical microbiology laboratory the development of a graphic user interface is a neces-
sity, with the most basic information regarding bacterial identity and AMR presented in an easy-to-read fash-
ion13,14. More advanced analysis of virulence factors, sequence types, phylogeny and plasmids would require 
bioinformatic skills. With the rapid development of sequencing-technology, computational power and bioin-
formatic tools, we believe that such an approach may be the future of routine analysis in clinical microbiology. 
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Furthermore, costs of sequencing are decreasing steadily and flow cells suitable for on-demand sequencing of 
bacterial genomes have reached the market. Currently, the price per Flongle flow cell, which according to the 
manufacturer can deliver up to 1–2 gigabytes of data, is $90 (https://nanoporetech.com/). By use of barcoding 
it should be possible to analyse several samples per flow cell, thereby reducing sequencing-costs to a level that is 
comparable to other molecular tests which are available in many routine microbiology laboratories.
In conclusion, we have shown that with a sequencing-based approach to blood culture diagnostics it is possible 
to identify pathogens and specific AMR-encoding genes using raw nanopore sequencing data, obtained within four 
hours after a blood culture is flagged as positive by the incubation system. Identification of pathogens was possible 
after 10 minutes of real-time sequencing, and all predefined AMR-encoding target genes and plasmids from the 
monoculture experiments were detected within one hour (Fig. 6). Furthermore, we demonstrate correct identifica-
tion of plasmids and blaCTX-M subtypes using de novo assembled nanopore contigs. Results from this study hold great 
promise for future applications in clinical microbiology and for health care surveillance purposes.
Methods
Bacterial strains. E. coli strain CCUG17620 and S. aureus strain CCUG35600 were obtained from Culture 
Collection University of Gothenburg, Sweden. E. coli strain NCTC13441 produces CTX-M-15 ESBL and was 
purchased from the culture collection at Public Health England and selected due to the availability of whole 
genome sequence data. E. coli strain A2-39 (blaCTX-M-gr.2), Klebsiella pneumoniae strain A2-23 (blaCTX-M-gr.1), and 
K. pneumoniae strain A2-37 (blaCTX-M-gr.9) were provided by the Norwegian National Advisory Unit on Detection 
of Antimicrobial Resistance (K-Res), University Hospital of North Norway, Tromsø.
Inoculation and incubation of blood cultures. For incubation of blood cultures the BACTEC (BD) 
system was used. Briefly, bacterial strains were grown overnight on agar plates and suspended into saline at a den-
sity of 0.5 McFarland units. The suspensions were diluted with saline to 10−6, and 500 µl of the bacterial dilution 
together with 5 ml untreated human blood were added to one BD BACTEC Plus Aerobic medium flask. Human 
blood was obtained from healthy anonymous donors via the blood bank at Oslo University Hospital. The flasks 
were incubated in a BD BACTEC FX blood culture instrument overnight and growth was confirmed by the sys-
tem. Samples from the cultures were directly used for DNA extraction and dilutions were plated on agar plates for 
CFU counting after overnight incubation.
Extraction of bacterial DNA from blood culture and nanopore sequencing. For extraction of 
bacterial DNA to be used for nanopore sequencing two commercial systems were used, the QIAamp BiOstic 
Bacteremia DNA Kit from Qiagen (Germany) and the MolYsis Plus kit from Molzym (Germany). DNA extrac-
tion was performed according to the manufacturer’s instructions. Purified DNA was then prepared for nanopore 
sequencing using the Rapid Barcoding Sequencing kit SQK-RBK004 (Oxford Nanopore, UK) following the man-
ufacturer’s protocol. The optional purification and concentration step with the Agencourt AMPure XP system 
(Beckman Coulter, USA) was included into the procedure. Sequencing was performed on MinION flow cells 
(R9.4.1 FLO-MIN106, Oxford Nanopore) and data collected using the MinKNOW software v3.6.5 (https://nan-
oporetech.com/nanopore-sequencing-data-analysis). Basecalling was done online through the EPI2ME service 
provided by Metrichor (UK).
Extraction of bacterial DNA and Illumina sequencing. DNA for Illumina sequencing was prepared 
using the CTAB method described elsewhere24. DNA concentrations and purity were determined using the 
NanoDrop One system and the Qubit 3.0 system with dsDNA HS assay kit (Thermo Fisher Scientific, USA). 
Library preparation was performed using the KAPA HyperPlus Kit from Kapabiosystems (USA) and adjusted 
to a final fragment length of about 600 bp. Adapters were NEXTflex DNA barcodes from Bioo Scientific (USA). 
Sequencing was done for 601 cycles on a MiSeq system using the MiSeq reaction kit version 3 at the Norwegian 
Sequencing Centre.
Nanopore sequencing data analysis. The MinKNOW platform generates sequencing data on the fly, out-
putting 4000 sequences per file using default settings. The first output file is produced approximately ten minutes 
after the start of the sequencing run. For this work each output file was processed separately keeping track of the 
time passed from the start of the sequencing. Combined sequencing reads from each complete run were de novo 
assembled using the Unicycler25 assembly pipeline setting–min_fasta_length flag to 500 bp. Reads recognized as 
generated from human DNA were omitted from further analysis and discarded.
Figure 6. Timeline for the information gathered from nanopore sequencing of positive blood cultures.
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Taxonomy classification. In addition to the online WIMP v3.2.118 ONT analysis tool, raw sequencing 
reads (≥ 300 bp) were also taxonomically classified by Centrifuge 1.0.4 using default settings (minimum length 
of partial hits min_hitlen = 22; at most k = 5 distinct assignments for each read; no preferred/excluded taxa) and 
bacteria, archaea, virus and human indexing scheme (release 12.062016.)17. The output was summarized using the 
centrifuge-kreport command. Additionally, we used the BLAST search algorithm with the NCBI RefSeq (release 
93, 16.03.2019) and NCBI Prokaryotic RefSeq (RefProk, release 18.10.2018) databases. Only hits with ≥ 85% 
similarity, E-value ≤ 10−6 and with ≥ 80% coverage were kept. The ANI was calculated using the orthoANIu 
online calculator26.
Plasmid detection. Raw sequencing reads (≥ 300 bp) were searched against the comprehensive plasmid 
sequences database from Brooks et al.19 using BLAST (downloaded March2019), Only hits with ≥ 80% similar-
ity, E-value ≤ 10−6 and with ≥ 80% coverage of the query were kept. Assembled contigs were initially searched 
against the NCBI plasmid database using the PlasmidFinder v.2.0.227 and positive hits were additionally con-
firmed through the search against the PLSDB plasmid database v.2019_06_0328.
AMR genes search. Raw sequencing reads (≥ 300 bp) and assembled contigs tagged as plasmids, were 
searched against the nucleotide-based CARD (v3.0.1, release February2019)29 and ResFinder (release February 
2019)30 databases using BLAST. Only hits with ≥ 80% similarity, E-value ≤ 10-6 and with ≥ 50% coverage of the 
database entry were kept.
Illumina sequencing data analysis. Raw sequencing reads were read error corrected and assembled 
using SPAdes v.3.13.131. For taxonomy assignment, corrected unassembled reads were classified by Centrifuge 
1.0.4 as described above. Assembled contigs were searched against the RefProk database using BLAST (con-
tigs ≥ 10000 bp; hit length ≥ 10000 bp; similarity ≥ 85%). For plasmid and AMR gene search assembled contigs 
were analyzed using PlasmidFinder, CARD and ResFinder databases as described above.
Hybrid assembly, other software. Additionally, we used Unicycler for de novo hybrid assembly of com-
bined Illumina and nanopore reads using the “–min_fasta_length 500” flag and performed plasmid and AMR 
gene search as described above.
Genome coverage analysis. Each output file from the nanopore sequencing was BLAST searched against 
the reference genome sequence using 90% of the similarity threshold. The coverage was calculated as the propor-
tion of the genome that reads were mapping towards. BLAST results were summarized in additive fashion where 
for each time point n all previous output files (n-1, n-2,…1) were also taken. Hybrid assembly was used as the 
reference for E. coli A2-39, K. pneumoniae A2-37 and K. pneumoniae A2-23; nanopore assembly – for S. aureus 
CCUG35600 as this strain was not sequenced on Illumina platform. Genome sequence of E. coli NCTC13441 was 
downloaded from the ENA database (WGS project UFZF01) and of E. coli CCUG17620 (CP009072) - from the 
NCBI database.
All results were summarized and visualized in Matlab R2018b (MathWorks Inc., MA, USA) unless stated 
otherwise. Assembly graphs were visualized in Bandage32.
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on request.
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